Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, CloudbreakTM.
$2.30
As of 04/09/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.